Class of 2023
Scientific Area of Expertise: Cell Therapies, Genetic Engineering, T cell and Tumor Immunology
For unparalleled contributions to the conceptualization and optimization of chimeric antigen receptor (CAR) T cells, including engineering CARs that provide enhanced proliferation, survival, and potency to T cells, identifying CD19 as a target for CAR therapy, and designing CD19 CAR therapies for patients with relapsed, refractory acute lymphoblastic leukemia.
*Full-length biography pending